secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bio Green Med Solution, Inc. (BGMS)
CIK:        0001130166
Form:       8-K
Filed at:   2023-07-07T23:59:59+00:00
Accession:  0001104659-23-079107
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Cyclacel gets 180-day Nasdaq extension to Jan 2, 2024 to regain $1.00 bid price compliance
--------------------------------------------------------------------------------

- Received extension on July 5, 2023; must comply by January 2, 2024.
- Previously disclosed non-compliance on Jan 6, 2023; original cure period ended July 3, 2023.
- Company intends to cure via reverse stock split if necessary, within ten business days before extension expires.
- If not cured by Jan 2, 2024, Nasdaq will issue delisting notice; Company may appeal to Hearing Panel.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130166/000110465923079107/0001104659-23-079107-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130166/000110465923079107/tm2320788d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-079107

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer